Arax Advisory Partners’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.73K | Hold |
110
| – | – | ﹤0.01% | 2195 |
|
|
2025
Q1 | $4.69K | Buy |
110
+60
| +120% | +$2.56K | ﹤0.01% | 1803 |
|
|
2024
Q4 | $1.53K | Sell |
50
-34
| -40% | -$1.04K | ﹤0.01% | 2072 |
|
|
2024
Q3 | $1.93K | Hold |
84
| – | – | ﹤0.01% | 2077 |
|
|
2024
Q2 | $2.43K | Buy |
84
+34
| +68% | +$982 | ﹤0.01% | 1897 |
|
|
2024
Q1 | $1.03K | Sell |
50
-50
| -50% | -$1.03K | ﹤0.01% | 1150 |
|
|
2023
Q4 | $2.71K | Hold |
100
| – | – | ﹤0.01% | 979 |
|
|
2023
Q3 | $2.96K | Hold |
100
| – | – | ﹤0.01% | 964 |
|
|
2023
Q2 | $3.58K | Hold |
100
| – | – | ﹤0.01% | 926 |
|
|
2023
Q1 | $2.34K | Hold |
100
| – | – | ﹤0.01% | 980 |
|
|
2022
Q4 | $2.72K | Hold |
100
| – | – | ﹤0.01% | 910 |
|
|
2022
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 799 |
|
|
2022
Q2 | $4K | Hold |
100
| – | – | ﹤0.01% | 824 |
|
|
2022
Q1 | $7K | Hold |
100
| – | – | ﹤0.01% | 704 |
|
|
2021
Q4 | $10K | Hold |
100
| – | – | ﹤0.01% | 656 |
|
|
2021
Q3 | $13K | Hold |
100
| – | – | ﹤0.01% | 605 |
|
|
2021
Q2 | $12K | Buy |
+100
| New | +$12K | ﹤0.01% | 635 |
|
|
2020
Q4 | $13K | Hold |
100
| – | – | ﹤0.01% | 540 |
|
|
2020
Q3 | $11K | Hold |
100
| – | – | ﹤0.01% | 530 |
|
|
2020
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 554 |
|
|
2020
Q1 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 546 |
|